JAGXJaguar Health, Inc.

Nasdaq jaguar.health


$ 1.10 $ -0.10 (-8.33 %)    

Wednesday, 18-Sep-2024 15:56:53 EDT
QQQ $ 472.49 $ -2.05 (-0.43 %)
DIA $ 416.26 $ -1.07 (-0.26 %)
SPY $ 562.20 $ -1.67 (-0.3 %)
TLT $ 99.62 $ -1.25 (-1.24 %)
GLD $ 235.53 $ -1.83 (-0.77 %)
$ 1.1
$ 1.21
$ 1.10 x 500
$ 1.11 x 800
$ 1.10 - $ 1.27
$ 0.95 - $ 31.74
598,534
na
10.17M
$ 1.52
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

Jaguar Supports Proof-Of-Concept Studies For Rare Disease Indications With Results Expected By End Of 2024 And 2025

 why-jaguar-health-jagx-stock-is-down-15

Jaguar Health shares are trading lower by 15.4% during Tuesday's session. The company reported worse-than-expected second-q...

 jaguar-health-q2-eps-404-misses-111-estimate-sales-272m-miss-394m-estimate

Jaguar Health (NASDAQ:JAGX) reported quarterly losses of $(4.04) per share which missed the analyst consensus estimate of $(1.1...

 why-jaguar-health-stock-is-crashing

Jaguar Health shares are falling Tuesday after the company announced its phase 3 OnTarget trial did not meet its primary endpoi...

 jaguar-health-announces-webcast-on-july-23-to-discuss-phase-3-ontarget-trial-results-for-crofelemer

Will Include Updates On Cancer Supportive Care Portfolio And Expansion Of Make Cancer Less Shitty Program With MCLS Ambassadors

 jaguar-health-to-present-phase-3-ontarget-trial-results-for-its-cancer-supportive-care-drug-crofelemer-on-or-before-july-23-2024

Investor webcast on or before July 23 will include updates on Jaguar's cancer supportive care portfolio, including particip...

 jaguar-health-and-magdalena-biosciences-executes-out-license-deal-with-for-botanical-drug-candidate-for-schizophrenia

The drug candidate demonstrates antipsychotic activity and has a mechanism of action distinct from FDA-approved therapies for s...

 whats-going-on-with-jaguar-health-stock

Jaguar Health shares are falling after the stock effected a reverse split at an exchange ratio of 1-for-60 Thursday, in order t...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION